{"name":"Michael B. Atkins, MD","slug":"michael-b-atkins-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQclNmUERUc1FiNnlvdm9GYjZrdVF4Q3FKTHU5WGhsUzc2OHpCR25iUGNPTmdVODRNQTVyWTVvcXJBR3N4a3lUQ1Z6WktyWnJIS19hTzdTQW0zMXBHc2FqTVNYbDhqdE9zSFo2T1FvN24tcUptVUVBSk1vRzc0VnlHTVNDOTZleHFvVTB0RWJucm1aWkR3YVBPWg?oc=5","date":"2026-02-26","type":"pipeline","source":"Medscape Reference","summary":"Treatment Options and Prognoses for Advanced Melanoma - Medscape Reference","headline":"Treatment Options and Prognoses for Advanced Melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQaExjdENQdDkwNkU3X044UGdDX0RzV1FUVnB0Z054S3o0RU1SaHZ3S0pSd2YxQ1l0WmlCYlpzU3hucGZPbUhvUHA0em5rcXZNNGs0X2pxallTSUx2RU1GN2RmaXAtVGJJY0o0aU9fQlBlQlhRbHpQbEhzUGZ3Yk5DejhIZTFsZ0tSY1lNVGNFWUJyUlhGejhHeGliSTgwRk5GRkNXSUtTYjRUaGU5S1FmNlNUTElZdG9fUUNGUTdR?oc=5","date":"2024-10-30","type":"pipeline","source":"ASCO Daily News","summary":"How Does Cytoreductive Nephrectomy Continue to Fit in the Evolving Treatment Landscape of Metastatic RCC? - ASCO Daily News","headline":"How Does Cytoreductive Nephrectomy Continue to Fit in the Evolving Treatment Landscape of Metastatic RCC?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE5mNUhGZ3ZsejVQSDViRFBaWU1NaTRwSzAwdU94Yk9NUXFrTE5FTEhhUTBVWWVQeWRlQm83ZmpfN0d1OWs0M25ILWdXRkJkTlJnYW41d2gwUQ?oc=5","date":"2023-12-01","type":"pipeline","source":"ASCO Publications","summary":"Systemic Therapy for Melanoma: ASCO Guideline Update Q and A - ASCO Publications","headline":"Systemic Therapy for Melanoma: ASCO Guideline Update Q and A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQM1JxOE9OSEpfd2k1MFAtWk5VRWQ0SjMtRFJvRTF4X3FpYUVxVHJtYjNRM0dVTUZnaXdFR0prRUJwSi1vaFdDMEhadW5DNndfM0lSSGlBRkVlbTc4QWFxTkZpNXZJTl96Q1NJQWc3UTZTQlhpeEhvWVFWSExrMU5rSGw4TDdINm1NU29FWGxXUGRNLS1EYmNmd2RzSmxzWm1C?oc=5","date":"2023-05-29","type":"pipeline","source":"Targeted Oncology","summary":"Neoadjuvant Immunotherapy Expands Its Reach in Metastatic Melanoma - Targeted Oncology","headline":"Neoadjuvant Immunotherapy Expands Its Reach in Metastatic Melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOTmpwYlRLalhWWmRqVFhGNWtKblZ2S0FIN2dUbXpZTXRuOWd6aUdwZHNCd1BWQ0dnNHdzdjZwa1FOM1puUnF3eW1XQVF3ZlhrNlJDbnV5ZE9zYlFKei1OZFFoSGo3OFd6TVFVczdiWU04Z1ZVd3QwVXlqV080by1VaHliZDA4NXZCOEo0c2VVcnkyc1A0amx4aThNZGhFM1hnNmdFeS1sal9nbFFQTHFTNjdVMk5nbXF3d1AzbmEyemN0clR0TXBlRXpB?oc=5","date":"2022-06-20","type":"pipeline","source":"Oncology News Central","summary":"Enzalutamide Survival Benefit in Metastatic Prostate Cancer Persists Beyond Five Years - Oncology News Central","headline":"Enzalutamide Survival Benefit in Metastatic Prostate Cancer Persists Beyond Five Years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNRTY2blVHMlNPX2dFSnk1alRhSWtFTFEwRXdpUG9rZ19qT2xwM0tqOVo0ZDltb3pENFc4Z1FPWVZ6SjFoZlJESXE5c1R0U09GellsVVpJb3FXRlpPbV94RGQ0eVUzRVUwZWtWVFpWbUswVUplUFVfOUdXejRUVk1URnh2VXNEcXZDYlN1QWFwYmJBVElfWUpmSndQeDBfZXpUTVBVbkZlam9KWnk0VWgxNGhER2huNEg3VkVyRWxGbUtpSE8zaEp6U210c2w5NmZmb2wxbmxiOElTUzlGWF84WGtXLXI?oc=5","date":"2022-06-17","type":"pipeline","source":"Oncology News Central","summary":"Intermittent Therapy May Improve PFS in Metastatic CRC - Oncology News Central","headline":"Intermittent Therapy May Improve PFS in Metastatic CRC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNRTEyaW1vU1NUUnhJQTFEQ2prSXY2NE9jaE9zM2o3cDhNZzJsUnVYSjVJaFNLd1AxYXc0MHM2NzJnQ09RdG1XM3Yzc0hEeElxUzUtWWtyMVpWS29SU1Q1LXRGaG9pdVZmOUgySWdwSkJvc3hiMks1UHROV2hFMzdYTGJ1MUlhdHN2Q1A5bW9YTjVKdjg3LUV6UG01SzR1TzRHeGM2Q0NKWTRtQU5YWl9vRm1ZbWoxclZJd1dITHdqcjJOSnQ0?oc=5","date":"2021-12-10","type":"trial","source":"ascopost.com","summary":"DREAMseq Trial: In Advanced Melanoma With BRAF Mutations, Start With Immunotherapy - ascopost.com","headline":"DREAMseq Trial: In Advanced Melanoma With BRAF Mutations, Start With Immunotherapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5tNkFiNWViME1TSjN1RlBBbnMtdkNVUUtoVGY4N29vb29aUE1PdC04ZUJkT2tWUEdDbk55NjRNdkR0UTZFTWtKbERPcjlGbExzb0pOaTJRRFlhLV9MV2JlOXMtUURJRE9PX284YkVjT09HdDZpZ0NlVHZn?oc=5","date":"2019-01-29","type":"pipeline","source":"acsjournals.onlinelibrary.wiley.com","summary":"Choice of first‐line therapy in metastatic melanoma - acsjournals.onlinelibrary.wiley.com","headline":"Choice of first‐line therapy in metastatic melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE1BUlJBVGlrdUJMLTVMOEllaHh3T2o0dXRWN0c5Yi0tMUZmMG1VV0hUSDdWRFNWOGt6WkJNRm1XN3hOMnFFVDhKclBpQ010NXBVWlYwc1V6QllMSzZRTWg1ZmZGX3ozUUZndjhjV0xnRUNqZkth?oc=5","date":"2019-01-29","type":"pipeline","source":"acsjournals.onlinelibrary.wiley.com","summary":"Choice of first‐line therapy in metastatic melanoma - acsjournals.onlinelibrary.wiley.com","headline":"Choice of first‐line therapy in metastatic melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5KMkU4MFZFTDJpUjh1UUdrdFBJaXNuckNoMUlDV2RicjhZdGhMWEVFbHluN1NDbXZ2RjVMNXFOWmEtY09jRlBxOTRUTU00Sy1CZUxxSnc0NUQxalBYM0E?oc=5","date":"2018-07-03","type":"pipeline","source":"NEJM","summary":"Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis - NEJM","headline":"Melanoma Complicating Treatment with Natalizumab for Multiple Sclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNY0I3SVBfSjBudHFodjNlbEZ6dGdTcDNHZDBlbjRWUzRTY2JUUHdEOFU5TElOQ0xkRkIyY1lYSnp3anNsN012TTE5b0NwRm1MNEJLaEY0Ym5MY3Q2OVhHc3RlNUZYb2xLVGlaWENwS19xQVZWMmhneTl3Y1hRakdTWlJ1OHktTVlQaDM5TUxwaERtRFR0dHpqQXJ3TVl5aVVzMTBkY2RlZGRNQnZTbjZIZkFvTmhuVVY4Zl9YYk52VQ?oc=5","date":"2015-06-10","type":"pipeline","source":"ascopost.com","summary":"CheckMate 067: Dual Checkpoint Blockade Proves Effective in Advanced Melanoma - ascopost.com","headline":"CheckMate 067: Dual Checkpoint Blockade Proves Effective in Advanced Melanoma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}